The recent presidential election, although monumental, was not the only spectacle captivating the American public; the race for all 435 seats in the House of Representatives also garnered significant attention. Among the myriad of candidates vying for office were several healthcare professionals, each bringing their unique expertise to the ballot. As election results began to
Health
The scientific community thrives on transparency and integrity, particularly concerning conflicts of interest (COIs) that may bias research findings. The introduction of a voluntary field for COI statements in PubMed abstracts by the National Library of Medicine in 2017 aimed to enhance this transparency. However, a recent investigation reveals that the adoption of this feature
Journey Medical has recently announced that the FDA has granted approval for minocycline hydrochloride extended-release capsules, marketed under the name Emrosi, for the treatment of inflammatory lesions associated with rosacea in adult patients. This marks a significant advancement in dermatological care, given the persistent challenges faced with existing therapies for this chronic skin condition. The
A recent longitudinal study has shed light on a critical aspect of schizophrenia management: the correlation between relapse episodes and increased mortality rates. Conducted by Christoph Correll, MD, and his team at the Zucker School of Medicine at Hofstra/Northwell, the research highlights the vulnerability of individuals with schizophrenia, even those seemingly stable, to serious health
Recent findings from a phase III trial reveal that seltorexant, a novel investigational drug, substantially alleviates symptoms of Major Depressive Disorder (MDD) alongside insomnia in patients resistant to traditional antidepressant treatments. This new approach targets the orexin system, a unique mechanism that many existing antidepressants don’t address. This article delves into the trial’s highlights, seltorexant’s
The decision by the Southwest District Health in Idaho to cease providing COVID-19 vaccines across six counties represents a significant shift in public health policy not just locally, but potentially on a national scale. The path to this milestone was paved by a narrow 4-3 vote from the board, essentially categorizing a vital public health
Obstructive Sleep Apnea (OSA) is a condition that affects a considerable number of children, leading to significant health consequences if left unaddressed. Characterized by repeated episodes of complete or partial blockage of the upper airway during sleep, OSA can result in disrupted sleep patterns, daytime fatigue, and various metabolic complications. Recent findings have drawn attention
The healthcare system in Texas has recently come under immense scrutiny, particularly following the distressing case of a woman who lost her life after enduring a 40-hour wait for miscarriage care. This tragic incident emphasizes a broader issue within the state’s healthcare infrastructure, where systemic delays and inadequate resources often put vulnerable patients at risk.
In recent months, the organ donation landscape has undergone a tumultuous shift, ignited by disturbing reports surrounding a Kentucky case where a man was mistakenly declared dead. This incident, which emerged from a congressional hearing, unveiled a deeper issue regarding how death is determined in the context of organ donation. While the man in question
The recent results from the FINEARTS-HF trial have raised significant questions regarding the efficacy of finerenone, known commercially as Kerendia, in providing renal benefits for patients suffering from heart failure with mildly reduced or preserved ejection fraction. Despite the medication’s promising profile, a secondary analysis of the trial has shown that finerenone does not yield